-
Methodological quality assessment of included studies.
Methodological quality assessment of included studies. -
Forest plot diagram showing the effect of TXA on post-operative blood loss.
The black diamond signifies that the mean difference is in favour of TXA. The size of each square depends on the weight of each study. A green square is given to continuous... -
Risk of bias according to revised Cochrane risk-of-bias tool for randomized t...
Risk of bias according to revised Cochrane risk-of-bias tool for randomized trials. -
r37980778c78--3d91728437141a60a66530ea8374b39a
BackgroundThe effects of neuromuscular blocking agents (NMBAs) on adult patients with acute respiratory distress syndrome (ARDS) remain unclear. We performed a meta-analysis of... -
Characteristics of included trials.
PI, plaque index; GI, gingival index; PPD, probing pocket depth; CAL, clinical attachment loss; GR, gingival recession; BOP, bleeding on probing; NA, not available; CHX,... -
Baseline characteristics of participants.
Data are presented as mean±SD, median (interquartile range) or percent. Chi-square test for categorical variables, the unpaired t test or Mann-Whitney U test for continuous... -
Summary of the results.
The proteasome inhibitor MG-132 down-regulates (−) the ubiquitin-proteasome pathway (UPP). AMPK-activator AICAR and proteasome inhibitor MG-132 co-treatment activates (+) the... -
r37980778c78--7588184c0022082e19ece4312d3aaed8
The black diamond signifies that the mean difference is in favour of TXA. The size of each square depends on the weight of each study. A green square is given to continuous... -
Main characteristics of studies included in the meta-analysis of the effects ...
Main characteristics of studies included in the meta-analysis of the effects of omega-3 fatty acids on proteinuria among patients with diabetes. -
Ibrutinib increases the risk of hypertension and atrial fibrillation: Systema...
IntroductionIbrutinib is an oral covalent inhibitor of Bruton's tyrosine kinase approved for the treatment of patients with chronic lymphocytic leukemia (CLL), mantle cell... -
r37980778c78--b468014c3422d2f33500ddf205860869
review authors' judgments about each risk of bias item for each included study. + is “yes”, − is “no”, ? is “unclear”. -
Method for study search and selection for inclusion.
Method for study search and selection for inclusion. -
Population characteristics.
Data are expressed as mean ± standard error or as percentages. Abbreviations: CRP: C-reactive protein, DAS28: disease activity score using 28 joint counts, DMARDs:... -
Risk of bias assessment.
Table 2 Assessment of the risk of bias in individual studies based on (1) exposure determination which includes standardization of age and assessment of LUTS severity by IPSS... -
Patient Characteristics.
Abbreviations: AML, acute myeloid leukemia; sAML, secondary AML; ALL, acute lymphoblastic leukemia; PMF, primary myelofibrosis; CLL: chronic lymphoblastic leukemia; SAA, severe... -
Included RCTs and major characteristics of the studies and patient population.
Included RCTs and major characteristics of the studies and patient population. -
Study flow diagram.
Copyright information:Taken from "A randomized controlled trial of sucrose and/or pacifier as analgesia for infants receiving venipuncture in a pediatric emergency... -
Associations between use of macrolide antibiotics during pregnancy and advers...
BackgroundEvidence on adverse effects of maternal macrolide use during pregnancy is inconsistent. We conducted a systematic review and meta-analysis to investigate the... -
Trial Characteristics.
BMI = body mass index; C = crossover; CHO = carbohydrate; E = energy; HF = high fat; HOMA-IR = homeostasis model assessment of insulin resistance; IP = inpatient; LF = low fat;...
